Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.

[1]  R. Mehran,et al.  Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial. , 2014, European heart journal.

[2]  P. Jüni,et al.  Short versus long duration of DAPT after DES implantation: a meta-analysis. , 2014, Journal of the American College of Cardiology.

[3]  R. Mehran,et al.  The OPERA study: The tenor or baritone of shorter duration of DAPT? , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  E. Herzog,et al.  Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents. , 2014, The American journal of cardiology.

[5]  Jing Chen,et al.  Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation: A Meta-analysis of 3 Randomized Controlled Trials , 2014, Journal of cardiovascular pharmacology.

[6]  R. Mehran,et al.  Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome? , 2014, Current opinion in cardiology.

[7]  R. Peters,et al.  The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occlu , 2014, Journal of the American College of Cardiology.

[8]  J. Messenger,et al.  Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. , 2014, Journal of the American College of Cardiology.

[9]  M. Marjanović,et al.  Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention , 2013, Heart.

[10]  K. Alexander,et al.  Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status. , 2013, Journal of the American College of Cardiology.

[11]  M. Botteman,et al.  Estimating Preference-Based EQ-5D Health State Utilities or Item Responses from Neuropathic Pain Scores , 2012, The Patient - Patient-Centered Outcomes Research.

[12]  M. Hadamitzky,et al.  Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention , 2012, Circulation.

[13]  K. Anstrom,et al.  Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. , 2011, American heart journal.

[14]  D. Atar,et al.  Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. , 2011, European heart journal.

[15]  Harlan M Krumholz,et al.  Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): Design and Rationale of a Prospective Multicenter Registry , 2011, Circulation. Cardiovascular quality and outcomes.

[16]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[17]  S. Pocock,et al.  Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI , 2011, JACC. Cardiovascular interventions.

[18]  K. Alexander,et al.  In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™. , 2011, The American journal of cardiology.

[19]  S. Manoukian.  The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk. , 2010, The Journal of invasive cardiology.

[20]  S. Manoukian.  Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. , 2009, The American journal of cardiology.

[21]  M. Neary,et al.  Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer , 2007, Health and quality of life outcomes.

[22]  R. Califf,et al.  Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. , 2007, European heart journal.

[23]  John E. Brazier,et al.  Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D , 2005, Quality of Life Research.

[24]  K. Eagle,et al.  Validation of the EQ‐5D in patients with a history of acute coronary syndrome* , 2005, Current medical research and opinion.

[25]  R. Rabin,et al.  EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.

[26]  Jacob Cohen,et al.  The statistical power of abnormal-social psychological research: a review. , 1962, Journal of abnormal and social psychology.

[27]  F. Fortuin,et al.  Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: A meta‐analysis of randomized clinical trials , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[28]  K. Alexander,et al.  Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score. , 2011, American heart journal.

[29]  D. Ivanovski,et al.  Printed in U.SA , 1988 .